CTP of β-hCG vaccine

Product Overview

Alternative Name: Carboxy Terminus Peptide of β-human chorionic gonadotropin

Description: Carboxy Terminus Peptide (CTP) of β-human chorionic gonadotropin (β-hCG) was a candidate immunogen to develop immunocontraceptive vaccine for human application.

Updated date: May 30, 2018

Vertical Tabs

Status

Status Details:
  • Phase I trial with a synthetic CTP vaccine was successfully conducted in Australia by the WHO Task Force on Vaccines for Fertility Regulation. Phase II trials were subsequently initiated in Sweden, but stopped due to unacceptable adverse reactions.

Download Product Report